Get an alert when BIODEXA PHARMACEUTICALS (WALES) LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2027-09-30 (in 1y)

Last filed for 2025-12-31

Confirmation statement due

2026-12-03 (in 7mo)

Last made up 2025-11-19

Watchouts

1 item

Cash

£28K

+250% vs 2024

Net assets

-£3M

-30.8% vs 2024

Employees

4

-33.3% vs 2024

Profit before tax

-£813K

+4% vs 2024

Watchouts

Facts from the Companies House register and the latest accounts — not a rating

Accounts

2-year trend · latest reflected 2025-12-31

Metric Trend 2024-12-312025-12-31
Turnover
Operating profit -£828,000-£803,000
Profit before tax -£847,000-£813,000
Net profit -£818,000-£818,000
Cash £8,000£28,000
Total assets less current liabilities -£2,518,000-£3,448,000
Net assets -£2,636,000-£3,448,000
Equity -£2,636,000-£3,448,000
Average employees 64
Wages £218,000£210,000
Directors' remuneration

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Year-on-year

FY2024 → FY2025 · period ending 2025-12-31 vs 2024-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2024-12-312025-12-31
Return on capital employed 32.9%23.3%
Gearing (liabilities / total assets) 666.9%1984.2%
Current ratio 0.05x0.03x
Interest cover -43.58x-80.30x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Name history

Renamed 2 times since incorporation

  1. BIODEXA PHARMACEUTICALS (WALES) LIMITED 2023-05-15 → present
  2. MIDATECH PHARMA (WALES) LIMITED 2015-01-23 → 2023-05-15
  3. Q CHIP LIMITED 2003-10-10 → 2015-01-23

Audit & accounting basis

Accounting basis
FRS 101
Reporting scope
Standalone (parent only)
Abridged
Yes — abridged accounts (limited disclosure)
Auditor
PKF Littlejohn LLP
Audit opinion
Unqualified (clean)
Going concern
Material uncertainty disclosed

“We draw attention to note 2.3 to the financial statements, which indicates that there is a material uncertainty in relation to the company's ability to continue as a going concern. As detailed in that note, the company's future viability is dependent on the ability of its parent company to raise additional funds and provide ongoing financial support.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 29 resigned

Name Role Appointed Born Nationality
STAMP, Stephen Secretary 2019-09-09
POWELL, Fiona Mary Director 2026-01-14 Sep 1968 British
STAMP, Stephen Anthony Director 2019-09-09 Nov 1961 British
Show 29 resigned officers
Name Role Appointed Resigned
JONES, Michael Secretary 2007-10-01 2014-12-08
ROBBINS CHERRY, Nicholas John Secretary 2014-12-08 2019-09-09
CAPITAL LAW SECRETARIES LIMITED Corporate Secretary 2003-10-10 2007-10-01
SEVERNSIDE SECRETARIAL LIMITED Corporate Nominee Secretary 2003-10-10 2003-10-10
ALTSCHULER, David Simon Director 2013-09-05 2014-03-24
BARRY, Mark Dafydd Director 2003-10-10 2009-09-30
BROOK, Richard Anthony Director 2004-05-11 2009-10-14
CHANAS, Alex Director 2011-10-01 2013-02-12
COOK, Craig Richard, Dr Director 2018-06-01 2020-04-30
CURNOCK COOK, Jeremy Lawrence Director 2004-10-01 2006-05-22
DE BOUCAUD, Cedriane Marie Director 2008-01-15 2009-06-22
GRIFFITHS, Dominic John Finbar, Dr Director 2007-10-04 2010-08-06
HARRISON, Richard Leslie Director 2006-07-01 2009-10-14
KEEN, Peter Director 2011-07-01 2013-07-08
MACPHERSON, Johanna Kate, Dr Director 2003-10-10 2011-12-20
MITTERRAND, Maxime Fernand Director 2008-01-15 2009-07-26
OWEN, David Andrew Arlwydd, Dr Director 2006-02-20 2007-04-30
PALMER, Daniel David, Dr Director 2013-10-23 2014-12-09
PHILLIPS, James Neil, Dr Director 2014-12-08 2018-05-31
POWELL, Kenneth Leslie, Dr Director 2007-12-05 2014-12-08
ROBBINS CHERRY, Nicholas John Director 2014-12-08 2019-09-09
SMITH, Richard Ian Director 2009-10-14 2014-12-08
SPAREY, Timothy Jason, Dr Director 2012-11-19 2014-12-08
THEWLIS, David Director 2003-12-04 2006-02-20
TURTON, Simon Director 2014-03-24 2014-12-08
E-SYNERGY NOMINEES LIMITED Corporate Director 2009-10-14 2010-08-06
LIMBURG VENTURES BV Corporate Director 2011-09-15 2014-09-16
SEVERNSIDE NOMINEES LIMITED Corporate Nominee Director 2003-10-10 2003-10-10
STV NOMINEE LTD Corporate Director 2009-06-22 2014-12-08

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Biodexa Pharmaceuticals Plc Corporate entity Shares 75–100% 2016-04-06 Active

Filing timeline

Last 20 of 221 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2023-05-15 CERTNM Certificate change of name company
  • 2023-05-15 CONNOT Change of name notice
Date Type Category Description
2026-04-24 AA accounts Accounts with accounts type full
2026-02-05 AP01 officers Appoint person director company with name date PDF
2025-11-21 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-07-04 AA accounts Accounts with accounts type small
2024-11-20 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-06-27 AA accounts Accounts with accounts type small
2023-11-21 CS01 confirmation-statement Confirmation statement with updates PDF
2023-06-10 AA accounts Accounts with accounts type small
2023-05-23 PSC05 persons-with-significant-control Change to a person with significant control PDF
2023-05-15 CERTNM change-of-name Certificate change of name company
2023-05-15 CONNOT change-of-name Change of name notice
2022-12-05 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-06-24 AA accounts Accounts with accounts type small
2021-11-26 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-09-14 AA accounts Accounts with accounts type full
2021-08-02 AD01 address Change registered office address company with date old address new address PDF
2021-06-30 MR04 mortgage Mortgage satisfy charge full PDF
2020-11-19 CS01 confirmation-statement Confirmation statement with no updates PDF
2020-09-23 AA accounts Accounts with accounts type full
2020-05-06 TM01 officers Termination director company with name termination date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
4

last 12 months

Capital events
0

last 24 months

Officers appointed
1

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page